Skip to main content
. Author manuscript; available in PMC: 2007 Apr 20.
Published in final edited form as: J Natl Cancer Inst. 2006 Mar 15;98(6):382–388. doi: 10.1093/jnci/djj090

Fig. 3.

Fig. 3

Percentage of patients on chemotherapy who received a taxane as part of their regimen by calendar quarter of first chemotherapy claim, according to axillary lymph node status.